- Home
- HQL vs CLPT Comparison
HQL vs CLPT Comparison
Compare HQL & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HQL | CLPT |
|---|---|---|
| Founded | 1992 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 510.2M | 494.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | HQL | CLPT |
|---|---|---|
| Price | $17.12 | $12.49 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $27.67 |
| AVG Volume (30 Days) | 120.9K | ★ 607.8K |
| Earning Date | 01-01-0001 | 11-06-2025 |
| Dividend Yield | ★ 11.56% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.79 | N/A |
| Revenue | N/A | ★ $34,332,000.00 |
| Revenue This Year | N/A | $18.93 |
| Revenue Next Year | N/A | $51.64 |
| P/E Ratio | $17.08 | ★ N/A |
| Revenue Growth | N/A | ★ 12.83 |
| 52 Week Low | $11.34 | $9.76 |
| 52 Week High | $14.37 | $30.10 |
Technical Indicators
Market Signals| Indicator | HQL | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 51.70 | 31.18 |
| Support Level | $17.03 | $13.00 |
| Resistance Level | $17.35 | $13.55 |
| Average True Range (ATR) | 0.28 | 0.71 |
| MACD | -0.05 | 0.13 |
| Stochastic Oscillator | 27.61 | 10.06 |
Price Performance
Historical ComparisonAbout HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.